Table 1 Clinical, biochemical characteristics and radiation planning parameters of patients enrolled in this study
Variables | n |
|---|---|
Clinical and biochemical characteristics | |
Sex | |
Male | 80 (74.07%) |
Female | 28 (25.93%) |
Age (years) | |
Median | 54 |
Range | 37–77 |
Underlying liver disease | |
Hepatitis B | 97 (89.81%) |
Hepatitis C | 7 (6.48%) |
Alcoholic hepatitis | 3 (2.78%) |
None | 1 (0.93%) |
Maximum tumor diameter (cm) | |
Median | 2.3 |
Range | 0.7–4.9 |
AFP (ng/ml) a | |
Median | 33.13 |
Range | 0.8–7896 |
Child-Pugh score | |
5 | 97 (89.81%) |
6 | 11 (10.19%) |
ALBI grade | |
Grade 1 | 34 (31.48%) |
Grade 2 | 74 (68.52%) |
WBC count (×109/L) | |
Median | 4.86 |
Range | 1.53–9.4 |
PLT count (×109/L) | |
Median | 118 |
Range | 50–283 |
Radiation planning parameters | |
Isodose line of maximum dose | |
Median (range, %) | 72 (60–86) |
Residual normal liver volume | |
Median (range, cm3) | 1324 (834–2493) |
Mean dose of whole liver volume minus GTV | |
Median (range, Gy) | 9.07 (4.04–12.05) |
Dose received by volume of liver | |
D700c | 4.99 (1.40–13.50) |
BED10b of Plan target volume (PTV) | |
Median (range, Gy) | 100 (76.8–102.6) |